<p> ASPIRIN, SALICYLATES AND CANCER Organised by the Aspirin Foundation - Sponsored by Bayer Schering Pharma AG Marcus Beck Library, Royal Society of Medicine, Wimpole Street, London W1 Tuesday 23rd November 2010 PROGRAMME 11.00 Coffee in Marcus Beck Library</p><p>11.15 CHAIR: Professor Peter Elwood Department of Epidemiology, College of Medicine, Cardiff University Opening remarks Dr Gareth Morgan Project Manager for Older People’s Services, NHS Wales A brief summary of all cancer conditions</p><p>11.50 Professor Peter Rothwell Professor of Clinical Neurology, University of Oxford Effects on colorectal cancer risk in randomised trials of Aspirin</p><p>12.20 Professor Sir John Burn Professor of Clinical Genetics, Newcastle University Aspirin in the prevention and treatment of colorectal cancer</p><p>12.50 Press Briefing</p><p>13.15 Lunch served in the ENT Room (ground floor)</p><p>14.15 Professor Andrew Chan Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston Mode of action and dosage</p><p>14.35 Dr Luis Mur Deputy Leader of Bio-renewables & Environmental Change Research Division, Aberystwyth University Salicylate salts in plants</p><p>14.55 Professor Dion Morton Professor of Colorectal Surgery, University of Birmingham Colon cancer screening programmes and the place for Aspirin</p><p>15.15 Tea break in Marcus Beck Library</p><p>15.30 Professor Jack Cuzick Cancer Research UK Centre for Epidemiology, Mathematics & Statistics, London Aspirin and other NSAIDs for cancer prevention</p><p>15.50 Dr Elmar Detering Global Medical Affairs Physician (CardioAspirin) Bayer Schering Pharma AG A short overview from BSP meeting of experts, October 2010 in Berlin </p><p>16.10 Professor Gordon McVie, Senior Consultant, Instituto Europeo di Oncologia, Italy/ General Discussion - Contributions from all participants</p><p>17.30 Bayer / CompaniesClose of havemeeting no influence on agenda or content of the Aspirin Foundation meeting</p>